Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understanding when to seek financial planning advice is essential for achieving your goals. Be informed and make wise choices.
19,165 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Managed futures ETFs offer a path to diversification when risks rise across markets. This guide explains how they wor...
As markets swing in early 2026, many investors pay active fees for funds that closely track benchmarks. Here’s a fast...
Longbridge Financial has rolled out RetentionIQ, a program to protect broker-originated loan pipelines from direct re...
A federal jury in San Francisco ruled that Elon Musk misled Twitter investors ahead of the 2022 buyout, setting up a ...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
Anthropic's new findings on Claude's misalignment collide with Elon Musk's public remarks, as investors weigh AI narr...
A $2.2 million dividend portfolio is quietly generating $13,200 a month in cash flow while avoiding complex K-1 taxes...
A proposed federal gas tax holiday could lower fuel costs in the near term, but it threatens highway funding and long...
Treasury's crypto policy lead is pushing for CLARITY Act passage by summer 2026 and signaling a cautious, deliberatel...
Federal safety regulators are recalling more than coffee makers—about 17,600 Kidisle units—after reports of hot liqui...
Charles Schwab is partnering with Cboe to launch S&P 500 yes-or-no binary options, a first-of-its-kind move into pred...